MEI Pharma, Inc.
NASDAQ:MEIP
3.14 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 48.816 | 40.697 | 25.535 | 28.913 | 4.915 | 1.622 | 23.249 | 0 | 0 | 0 | 0 | 0 | 0 | 0.084 | 0.228 | 0.674 | 0.645 | -0.12 | 0.308 | 0.193 | 0.145 | 0.007 |
| Cost of Revenue
| 1.815 | 1.235 | 1.408 | 2.671 | 4.263 | 3.383 | 5 | 0.058 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0 |
| Gross Profit
| 47.001 | 39.462 | 24.127 | 26.242 | 0.652 | -1.761 | 18.249 | -0.058 | 0 | 0 | 0 | 0 | 0 | 0.084 | 0.228 | 0.674 | 0.645 | -0.12 | 0.308 | 0.193 | -0.355 | 0.007 |
| Gross Profit Ratio
| 0.963 | 0.97 | 0.945 | 0.908 | 0.133 | -1.086 | 0.785 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -2.448 | 1 |
| Reseach & Development Expenses
| 52.45 | 85.641 | 69.398 | 34.065 | 32.3 | 17.038 | 7.237 | 13.403 | 23.823 | 19.331 | 6.084 | 4.915 | 2.115 | 4.031 | 7.777 | 9.325 | 5.761 | 3.427 | 2.279 | 2.381 | 2.024 | 0 |
| General & Administrative Expenses
| 33.13 | 30.54 | 24.414 | 16.717 | 14.597 | 9.787 | 8.628 | 5.667 | 7.175 | 6.448 | 5.138 | 3.479 | 4.336 | 0 | 0 | 0 | 0.488 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.215 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 33.13 | 30.54 | 24.414 | 16.717 | 14.597 | 9.787 | 8.628 | 5.667 | 7.175 | 6.448 | 5.138 | 3.479 | 4.336 | 3.948 | 3.63 | 3.756 | 8.703 | 4.404 | 4.45 | 6.35 | 0.654 | 0 |
| Other Expenses
| -0.022 | -0.006 | 0.486 | 0 | 0 | 15.416 | 4.868 | 1.934 | 1.773 | 1.449 | 0 | 3.479 | 4.336 | 3.948 | 3.63 | 4.43 | 8.703 | 3.958 | 4.45 | 6.35 | 0.654 | 0.129 |
| Operating Expenses
| 85.58 | 116.181 | 93.812 | 50.782 | 46.897 | 26.825 | 15.865 | 21.004 | 32.771 | 27.228 | 11.222 | 8.394 | 6.451 | 7.979 | 11.407 | 13.755 | 14.464 | 7.385 | 6.729 | 8.731 | 2.678 | 0.129 |
| Operating Income
| -36.764 | -75.484 | -69.685 | -24.54 | -46.245 | -28.586 | 2.384 | -21.004 | -32.771 | -27.228 | -11.222 | -8.394 | -6.451 | -7.895 | -11.179 | -13.081 | -13.819 | -7.385 | -6.421 | -8.538 | -3.033 | -0.122 |
| Operating Income Ratio
| -0.753 | -1.855 | -2.729 | -0.849 | -9.409 | -17.624 | 0.103 | 0 | 0 | 0 | 0 | 0 | 0 | -93.988 | -49.031 | -19.408 | -21.425 | 61.542 | -20.847 | -44.238 | -20.917 | -17.429 |
| Total Other Income Expenses Net
| 1.581 | 21.03 | 19.118 | -21.475 | 29.427 | -9.705 | 0.287 | 0.143 | 0.078 | 0.081 | 0.037 | 0.833 | -0.459 | 11.178 | 12.404 | 0.674 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -31.838 | -54.454 | -50.567 | -46.015 | -16.818 | -40.067 | 2.671 | -20.861 | -32.693 | -27.147 | -11.185 | -7.522 | -6.78 | -7.895 | -11.179 | -12.407 | -13.819 | -7.385 | -6.421 | -8.538 | -3.033 | -0.122 |
| Income Before Tax Ratio
| -0.652 | -1.338 | -1.98 | -1.591 | -3.422 | -24.702 | 0.115 | 0 | 0 | 0 | 0 | 0 | 0 | -93.988 | -49.031 | -18.408 | -21.425 | 61.542 | -20.847 | -44.238 | -20.917 | -17.429 |
| Income Tax Expense
| -4.948 | 0.284 | 0.008 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.003 | 0.001 | 0.001 | 0 | 0 | 0 | 0.001 |
| Net Income
| -31.838 | -54.738 | -50.575 | -46.016 | -16.819 | -40.068 | 2.67 | -20.862 | -32.694 | -27.148 | -11.186 | -7.523 | -6.781 | -7.896 | -11.18 | -12.41 | -13.82 | -7.386 | -6.421 | -8.538 | -3.033 | -0.123 |
| Net Income Ratio
| -0.652 | -1.345 | -1.981 | -1.592 | -3.422 | -24.703 | 0.115 | 0 | 0 | 0 | 0 | 0 | 0 | -94 | -49.035 | -18.412 | -21.426 | 61.55 | -20.847 | -44.238 | -20.917 | -17.571 |
| EPS
| -4.78 | -8.8 | -8.99 | -10.1 | -4.73 | -19.34 | 1.4 | -12.2 | -23.2 | -27.06 | -22.02 | -66.94 | -106.46 | -128.98 | -183.6 | -218.03 | -262.42 | -155.67 | -135.33 | -186.44 | -69.96 | -2.97 |
| EPS Diluted
| -4.78 | -8.75 | -8.84 | -10.1 | -4.65 | -19.34 | 1.45 | -12.13 | -23.18 | -27.06 | -22.02 | -66.94 | -106.46 | -128.98 | -183.6 | -218.03 | -262.42 | -155.67 | -135.33 | -186.44 | -69.96 | -2.97 |
| EBITDA
| -37.981 | -95.91 | -87.522 | -1.561 | -73.797 | -18.828 | 2.469 | -20.946 | -32.707 | -27.178 | -11.177 | -9.214 | -5.979 | -7.895 | -11.179 | -13.081 | -13.819 | -7.385 | -6.421 | -8.538 | -3.033 | -0.122 |
| EBITDA Ratio
| -0.778 | -2.357 | -3.428 | -0.054 | -15.015 | -11.608 | 0.106 | 0 | 0 | 0 | 0 | 0 | 0 | -93.988 | -49.031 | -19.408 | -21.425 | 61.542 | -20.847 | -44.238 | -20.917 | -17.429 |